OHSU

IRB #

IRB00010224

Title

A Phase II Open-Label, Single-Arm, Two Stage, Multicenter Trial of Pracinostat in Combination With Azacitidine in Elderly (Age ≥ 65 Years) Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Principal Investigator

Elie Traer

Study Purpose

The specific purpose of this study is to find out what effects, good and bad, the study drug in combination with azacitidine has on participants with newly diagnosed acute myeloid leukemia (AML).

Medical Condition(s)

Newly diagnosed AML.

Eligibility Criteria

65 or Greater Years of Age with Newly Diagnosed AML.

Age Range

65 - 110

Healthy Volunteers Needed

No

Duration of Participation

Participants will be seen every three months in clinic until their leukemia gets worse.

Minors Included

No

Contact

Nan Subbiah 503-494-4603
or
Clinical Trials Information Line: Phone 503-494-1080 or trials@ohsu.edu

Sponsor

MEI Pharma, Inc.

Recruitment End

01/01/2015

Compensation Provided

No


Go Back